Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Issues

IL-17_RA-Signalweg

IL-17_RA-Signalweg

Der Angriff am Interleukin-17-Signalweg ist ein interessantes innovatives Therapieziel bei der mittelschweren bis schweren Psoriasis. Durch die Blockade des spezifischen Rezeptors...

Going beyond undetectable: a review of the unmet long-term health needs of people living with HIV

Going beyond undetectable: a review of the unmet long-term health needs of people living with HIV

Overall prevalence of HIV in Europe   Since surveillance of the HIV epidemic began, more than half a million (504,455) HIV diagnoses have been reported in EU/EEA countries (Austria, Belgium,...

Efficacia e tollerabilità di pantoprazolo

Efficacia e tollerabilità di pantoprazolo

Direttore del Dipartimento di Medicina Interna Direttore dell’Unità di Gastroenterologia e Epatologia Università degli Studi di Genova – Genova, Italia Circa 30 anni fa l’avvento di...

Towards a new era of personalised ITI treatment

Towards a new era of personalised ITI treatment

In patients with severe haemophilia it is known that the incidence of inhibitor is around 30%, the potential impact of the type of factor VIII (FVIII) product administered still being disputed.1...

Dymista®: un nuevo logro en el tratamiento de la rinitis alérgica

Dymista®: un nuevo logro en el tratamiento de la rinitis alérgica

Aunque los corticoesteroides intranasales (CEIN) constituyen el tratamiento más eficaz de la rinitis alérgica (RA) (8;9), no todos los pacientes experimentan un alivio óptimo de los síntomas...

Dymista®: una classe a sé stante per il trattamento della rinite allergica

Dymista®: una classe a sé stante per il trattamento della rinite allergica

Benché i corticosteroidi intranasali (INS) siano il trattamento più efficace per la rinite allergica (RA)(8;9), non tutti i pazienti ottengono con essi un controllo ottimale dei sintomi(10)....

Dymista®: in a class of its own for the treatment of allergic rhinitis

Dymista®: in a class of its own for the treatment of allergic rhinitis

Although intranasal corticosteroids (INS) are the most effective allergic rhinitis (AR) treatment(8;9), not all patients achieve optimal symptom relief whilst taking them(10). Treatment practices as...

Dymista®: Eine Klasse für sich* in der Behandlung der allergischen Rhinitis

Dymista®: Eine Klasse für sich* in der Behandlung der allergischen Rhinitis

Obwohl intranasale Kortikosteroide (INS) die effektivste Therapie der allergischen Rhinitis (AR) sind(8;9), erreichen nicht alle Patienten während ihres Gebrauchs eine optimale Linderung ihrer...

Malignes Melanom

Malignes Melanom

Die Immuntherapie, die die natürliche Krebsabwehr des Immunsystems verstärkt, hat die Überlebenszeiten von Patienten mit malignem Melanom deutlich verlängert. Moderne gentechnische Verfahren...

Lansoprazolo: un trattamento efficace per la compliance dei pazienti e per la prevenzione dell'ulcera

Lansoprazolo: un trattamento efficace per la compliance dei pazienti e per la prevenzione dell'ulcera

Direttore del Dipartimento di Medicina Interna Direttore dell’Unità di Gastroenterologia e Epatologia Università degli Studi di Genova – Genova, Italia È risaputo che i farmaci...

1 … 25 26 27 28 29 … 38

Search Issues

RSS Feeds

  • All issues

Specialties

Click below to filter the KOM articles by specialty...

  • Allergy & Immunology
  • Cardiology
  • Conference
  • Critical Care
  • Dentistry
  • Dermatology
  • Diabetes & Endocrinology
  • Gastroenterology
  • General Medicine
  • Haematology
  • Hepatology
  • Infectious Diseases
  • Metabolic Disorders
  • Neurology
  • Nursing
  • Obstetrics & Gynaecology
  • Oncology
  • Paediatrics
  • Psychiatry
  • Rheumatology
  • Surgery Insights
  • Urology

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Register

Register

Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

Share

Copyright © 2000-2026 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa